+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Carglumic Acid - Global Strategic Business Report

  • PDF Icon

    Report

  • 192 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5309845
The global market for Carglumic Acid was estimated at US$144.2 Million in 2023 and is projected to reach US$206.6 Million by 2030, growing at a CAGR of 5.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Carglumic Acid Market - Key Trends & Drivers Summarized

What Is Driving the Increased Focus on Carglumic Acid in Healthcare?

Carglumic acid, primarily used to treat hyperammonemia in patients with N-acetylglutamate synthase (NAGS) deficiency, is gaining significant traction in the global healthcare market. The drug, classified as an orphan drug by the U.S. FDA and the European Medicines Agency (EMA), plays a critical role in the treatment of rare metabolic disorders. The market for carglumic acid is expanding due to heightened awareness of rare genetic conditions and the rising emphasis on early diagnosis and targeted therapies. With increasing advancements in genetic testing and precision medicine, healthcare providers are now better equipped to diagnose and manage conditions that require carglumic acid, thereby propelling market growth.

How Are Innovations and Research Impacting the Carglumic Acid Market?

Research and development activities are fundamental to the expansion of the carglumic acid market. Pharmaceutical companies are focusing on developing improved formulations and delivery methods to enhance patient compliance and therapeutic outcomes. Recent studies are exploring the broader applications of carglumic acid in treating other metabolic disorders beyond NAGS deficiency, potentially widening its use case and market potential. Strategic collaborations between research institutions and pharmaceutical companies are further accelerating the development of new therapies. Moreover, ongoing clinical trials aimed at proving the efficacy of carglumic acid in combination with other drugs are opening new avenues for market growth.

What Are the Regulatory and Pricing Dynamics Shaping the Market?

Regulatory frameworks and pricing strategies are critical to the carglumic acid market. Due to its classification as an orphan drug, carglumic acid benefits from regulatory incentives, including market exclusivity, tax credits, and fee reductions, which encourage pharmaceutical companies to invest in its development. However, the high cost of treatment remains a challenge, as carglumic acid therapy can be expensive, limiting its accessibility in regions with underdeveloped healthcare systems. Consequently, government and private insurance reimbursement policies play a pivotal role in determining the drug's market reach. Pharmaceutical companies are also exploring patient assistance programs to improve affordability and access, especially in emerging markets.

What Drives the Growth in the Carglumic Acid Market?

The growth in the carglumic acid market is driven by several factors, including the increasing prevalence of rare metabolic disorders, advancements in genetic screening, and enhanced healthcare infrastructure. Rising awareness among healthcare professionals about NAGS deficiency and similar conditions is leading to early diagnosis and treatment, thereby boosting the demand for carglumic acid. The development of more efficient supply chains and distribution networks, especially in developing regions, is making the drug more accessible. Additionally, supportive government policies and the increasing focus on orphan drug development by pharmaceutical companies are creating favorable market conditions. Together, these factors contribute to the robust growth trajectory of the carglumic acid market.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Orally Disintegrating Tablets segment, which is expected to reach US$105.6 Million by 2030 with a CAGR of a 5.9%. The Dispersible Tablets segment is also set to grow at 4.8% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was estimated at $38.3 Million in 2023, and China, forecasted to grow at an impressive 9.2% CAGR to reach $48.7 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Carglumic Acid Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Carglumic Acid Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Carglumic Acid Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Aktteva Biopharma LLP., Apothecon Pharmaceuticals Pvt Ltd, Biophore India Pharmaceuticals Pvt Ltd, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 38 Featured):

  • Aktteva Biopharma LLP.
  • Apothecon Pharmaceuticals Pvt Ltd
  • Biophore India Pharmaceuticals Pvt Ltd
  • Civentichem LLC
  • Dipharma Francis S.r.I
  • Dipharma S A
  • Manus Aktteva Biopharma LLP
  • NOVITIUM PHARMA LLC
  • NURAY CHEMICALS
  • Recoedati S.p.A
  • Recordati Rare Diseases Inc
  • Suven Life Sciences Limited

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of COVID-19 and a Looming Global Recession
  • Carglumic Acid - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increasing Prevalence of Rare Metabolic Disorders Driving Demand for Carglumic Acid
  • Advancements in Genetic Research and Personalized Medicine Boosting Market Growth
  • Rising Awareness and Diagnosis Rates of Urea Cycle Disorders
  • Expansion of Orphan Drug Designation Incentivizing Development and Distribution
  • Favorable Regulatory Frameworks and Accelerated Drug Approval Processes
  • Growing Focus on Pediatric Treatments and Specialized Pharmaceuticals
  • High Cost of Treatment Posing Challenges to Market Accessibility
  • Development of Novel Drug Delivery Systems Enhancing Patient Compliance
  • Emerging Markets Offering Untapped Opportunities for Carglumic Acid Sales
  • Increase in Government Funding for Research on Rare Diseases
  • Rising Competition from Alternative Treatments and Therapies
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Carglumic Acid Market Analysis of Annual Sales in US$ for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Carglumic Acid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Carglumic Acid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Carglumic Acid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Orally Disintegrating Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Orally Disintegrating Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Orally Disintegrating Tablets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Dispersible Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Dispersible Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Dispersible Tablets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Other Delivery Formats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Other Delivery Formats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Other Delivery Formats by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 21: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 22: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Carglumic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 24: USA Historic Review for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 25: USA 16-Year Perspective for Carglumic Acid by Delivery Format - Percentage Breakdown of Value Sales for Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats for the Years 2014, 2024 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 27: USA Historic Review for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 28: USA 16-Year Perspective for Carglumic Acid by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 31: Canada 16-Year Perspective for Carglumic Acid by Delivery Format - Percentage Breakdown of Value Sales for Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats for the Years 2014, 2024 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 33: Canada Historic Review for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 34: Canada 16-Year Perspective for Carglumic Acid by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
JAPAN
  • Carglumic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 35: Japan Recent Past, Current & Future Analysis for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 36: Japan Historic Review for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 37: Japan 16-Year Perspective for Carglumic Acid by Delivery Format - Percentage Breakdown of Value Sales for Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats for the Years 2014, 2024 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 39: Japan Historic Review for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 40: Japan 16-Year Perspective for Carglumic Acid by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
CHINA
  • Carglumic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 41: China Recent Past, Current & Future Analysis for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 42: China Historic Review for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 43: China 16-Year Perspective for Carglumic Acid by Delivery Format - Percentage Breakdown of Value Sales for Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats for the Years 2014, 2024 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 45: China Historic Review for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 46: China 16-Year Perspective for Carglumic Acid by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
EUROPE
  • Carglumic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 47: Europe Recent Past, Current & Future Analysis for Carglumic Acid by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Carglumic Acid by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 49: Europe 16-Year Perspective for Carglumic Acid by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 52: Europe 16-Year Perspective for Carglumic Acid by Delivery Format - Percentage Breakdown of Value Sales for Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats for the Years 2014, 2024 & 2030
  • Table 53: Europe Recent Past, Current & Future Analysis for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 55: Europe 16-Year Perspective for Carglumic Acid by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
FRANCE
  • Carglumic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 57: France Historic Review for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 58: France 16-Year Perspective for Carglumic Acid by Delivery Format - Percentage Breakdown of Value Sales for Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats for the Years 2014, 2024 & 2030
  • Table 59: France Recent Past, Current & Future Analysis for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 60: France Historic Review for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 61: France 16-Year Perspective for Carglumic Acid by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
GERMANY
  • Carglumic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 63: Germany Historic Review for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 64: Germany 16-Year Perspective for Carglumic Acid by Delivery Format - Percentage Breakdown of Value Sales for Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats for the Years 2014, 2024 & 2030
  • Table 65: Germany Recent Past, Current & Future Analysis for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 66: Germany Historic Review for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 67: Germany 16-Year Perspective for Carglumic Acid by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 69: Italy Historic Review for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 70: Italy 16-Year Perspective for Carglumic Acid by Delivery Format - Percentage Breakdown of Value Sales for Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats for the Years 2014, 2024 & 2030
  • Table 71: Italy Recent Past, Current & Future Analysis for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 72: Italy Historic Review for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 73: Italy 16-Year Perspective for Carglumic Acid by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Carglumic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 75: UK Historic Review for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 76: UK 16-Year Perspective for Carglumic Acid by Delivery Format - Percentage Breakdown of Value Sales for Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats for the Years 2014, 2024 & 2030
  • Table 77: UK Recent Past, Current & Future Analysis for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 78: UK Historic Review for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 79: UK 16-Year Perspective for Carglumic Acid by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
SPAIN
  • Table 80: Spain Recent Past, Current & Future Analysis for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 81: Spain Historic Review for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 82: Spain 16-Year Perspective for Carglumic Acid by Delivery Format - Percentage Breakdown of Value Sales for Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats for the Years 2014, 2024 & 2030
  • Table 83: Spain Recent Past, Current & Future Analysis for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 84: Spain Historic Review for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 85: Spain 16-Year Perspective for Carglumic Acid by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
RUSSIA
  • Table 86: Russia Recent Past, Current & Future Analysis for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 87: Russia Historic Review for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 88: Russia 16-Year Perspective for Carglumic Acid by Delivery Format - Percentage Breakdown of Value Sales for Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats for the Years 2014, 2024 & 2030
  • Table 89: Russia Recent Past, Current & Future Analysis for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 90: Russia Historic Review for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 91: Russia 16-Year Perspective for Carglumic Acid by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 93: Rest of Europe Historic Review for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 94: Rest of Europe 16-Year Perspective for Carglumic Acid by Delivery Format - Percentage Breakdown of Value Sales for Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats for the Years 2014, 2024 & 2030
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 96: Rest of Europe Historic Review for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 97: Rest of Europe 16-Year Perspective for Carglumic Acid by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Carglumic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Carglumic Acid by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Carglumic Acid by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 100: Asia-Pacific 16-Year Perspective for Carglumic Acid by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Carglumic Acid by Delivery Format - Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 103: Asia-Pacific 16-Year Perspective for Carglumic Acid by Delivery Format - Percentage Breakdown of Value Sales for Orally Disintegrating Tablets, Dispersible Tablets and Other Delivery Formats for the Years 2014, 2024 & 2030
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Carglumic Acid by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 106: Asia-Pacific 16-Year Perspective for Carglumic Acid by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
AUSTRALIA
  • Carglumic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Carglumic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Carglumic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Carglumic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Carglumic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aktteva Biopharma LLP.
  • Apothecon Pharmaceuticals Pvt Ltd
  • Biophore India Pharmaceuticals Pvt Ltd
  • Civentichem LLC
  • Dipharma Francis S.r.I
  • Dipharma S A
  • Manus Aktteva Biopharma LLP
  • NOVITIUM PHARMA LLC
  • NURAY CHEMICALS
  • Recoedati S.p.A
  • Recordati Rare Diseases Inc
  • Suven Life Sciences Limited

Table Information